CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
20 hedge funds and large institutions have $910K invested in CASI Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
54% less capital invested
Capital invested by funds: $1.99M → $910K (-$1.08M)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$218K | |
| 2 | +$64.6K | |
| 3 | +$41.5K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3.07K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.69K |
Top Sellers
| 1 | -$220K | |
| 2 | -$144K | |
| 3 | -$93.9K | |
| 4 |
Jane Street
New York
|
-$89.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$8.75K |